Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil as Add-On Treatment of Psychotic Symptoms in Patients With Dementia of the Alzheimer's Type
NCT00190021Phase 3Unknown
- Sponsor
- Be'er Sheva Mental Health Center
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in Alzheimer's disease (AD), psychosis, sponsored by Be'er Sheva Mental Health Center. Status: unknown.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)psychosis
Beyond the preview
Go deeper on NCT00190021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190021.